Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: Ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions

This publication has 34 references indexed in Scilit:

• A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting
  New England Journal of Medicine, 1998
• Toward a New Frontier in Myocardial Reperfusion Therapy
  Circulation, 1998
• Pharmacokinetics and Effect of Ticlopidine on Platelet Aggregation in Subjects with Normal and Impaired Renal Function
  The Journal of Clinical Pharmacology, 1997
• A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery Stents
  New England Journal of Medicine, 1996
• A Randomized Comparison of Combined Ticlopidine and Aspirin Therapy Versus Aspirin Therapy Alone After Successful Intravascular Ultrasound–Guided Stent Implantation
  Circulation, 1996
• Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors
  British Journal of Haematology, 1995
• Long-term angiographic and clinical outcome after implantation of a ballon-expandable stent in the native coronary circulation
  Journal of the American College of Cardiology, 1994
• Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty.
  Circulation, 1992
• The Action of Ticlopidine on Human Platelets
  Thrombosis and Haemostasis, 1990
• Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
  Journal of Clinical Investigation, 1985